Results derived from these three databases all indicated that elevated levels of OAS1, OAS2, OAS3, and OASL were associated with poor overall survival (OS) in pancreatic cancer (Figure 7B). This evidence concerns the gene OAS3 and familial pancreatic carcinoma.